Product information
Methyl p-toluate
- CAS No.
- 99-75-2
- Formula
- C₉H₁₀O₂
- Molecular weight
- 150.17 g/mol
- Synonyms
- methyl P-methylbenzoate
Capot can support Methyl p-toluate from kilogram-scale production through long-term commercial supply, with process and quality support tailored to customer specifications.
Product overview
The structure contains a benzene ring and the following functional or substituent features: ester group, methyl substituent.
Application areas
Depending on the synthesis route and project requirements, this product may also be suitable for other related organic synthesis applications.
Potential uses
- The ester group may be hydrolyzed or transesterified to provide corresponding carboxylic-acid or ester derivatives.
Typical specifications
| Item | Typical specification |
|---|---|
| Purity | NLT 98% |
Specific quality parameters can be confirmed based on project and application requirements. The final product specifications are those agreed upon by both parties.
Production & quality support
Quality support
- Process development, optimization and scale-up
- Analytical testing and quality control
- Batch documentation and technical information support
Scale & supply
- Commercial manufacturing and supply capabilities from kilogram to ton scale
- Assessment of customer specifications and quality requirements
- Long-term reliable supply support
Supply scale：Kilogram scale
Available documents
- Product specification (SPEC)
- Safety data sheet (SDS)
- Certificate of analysis (COA)
- Route of synthesis (ROS)
- Method of analysis (MOA)
- Analytical data
- Regulatory and quality declarations
Related documents may be evaluated and provided based on the product, project stage, progress of cooperation, and confidentiality requirements.
Website information is for reference only. For product specifications and related materials, please refer to the final official documents confirmed by our company.
Custom requirements
Start a conversation
Request a quote
Tell us the quantity and technical requirements. We will follow up shortly.